Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    -0.002 (-8.70%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Update on bulk sampling programme

14 Feb 2019 07:00

RNS Number : 9957P
Ironveld PLC
14 February 2019
 

14 February 2019

Ironveld Plc

("Ironveld" or the "Company")

 

Update on bulk sampling programme

 

Ironveld plc, the owner of a High Purity Iron ("HPI"), Vanadium and Titanium project ("the Project") located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa is pleased to provide the following update on the previously announced bulk sampling programme.

 

Further to the announcement on 18 January 2019, the Company can confirm that the potential off-taker has now concluded its metallurgical tests. The Company will hold discussions with the potential off-taker over the coming weeks with the aim of reaching agreement on the terms of an offtake agreement.

 

The Company also announces it remains in detailed discussions with two potential development partners for the Project, who are currently engaged in an extensive due diligence process that may lead to offers that would facilitate the commencement of smelting operations by the Company. The Company will provide further updates to the market in due course.

 

Peter Cox, CEO of Ironveld, said:

"We are very pleased with the interest shown in our high-quality ore. In addition, the interest from the potential industrial partners is highly encouraging. I look forward to updating shareholders in due course."

 

Ends

 

Ironveld plc

Peter Cox, Chief Executive

c/o Camarco

020 3757 4980

Shore Capital

Jerry Keen / Toby Gibbs

 

020 7408 4090

Camarco

Gordon Poole / Kimberley Taylor / Thayson Pinedo

020 3757 4997

 

Notes to Editors:

Ironveld (IRON.LN) is the owner of a High Purity Iron, Vanadium and Titanium project located on the Northern Limb of the Bushveld Complex in Limpopo Province South Africa. Ironveld expects to mine its own VTM ore as feedstock for a 7.5 MW DC smelter which will produce speciality iron products including high purity iron powder as well as vanadium and titanium slag products.

The Definitive Feasibility Study published in April 2014 confirms the project's viability to deliver an exceptionally high grade iron product (99.5% Fe) called High Purity Iron which commands a premium in the market place. Vanadium and Titanium slag containing commercial grades of vanadium and titanium will also be produced and sold.

Ironveld's Board includes; Giles Clarke as Chairman, Peter Cox as CEO, Vred von Ketelhodt as CFO, Nick Harrison, Rupert Fraser and Duncan George Harvey as a Non-Executive Directors.

Ironveld is an AIM traded company. For further information on Ironveld please refer to www.ironveld.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQZLBFKLFEBBD
Date   Source Headline
3rd Sep 20207:00 amRNSFurther Extension of IIG Option Agreement
18th Aug 20202:53 pmRNSChange of Registered Office address
11th Jun 20207:00 amRNSBridge Loan Facility and Extension of IIG Option
27th May 20207:00 amRNSUpdate on IIG Option Agreement
23rd Apr 20208:09 amRNSBlocklisting Return
30th Mar 202010:30 amRNSInterim results
30th Mar 202010:00 amRNSStrategic Partnership and Conditional Fundraising
4th Feb 20209:21 amRNSNotification of Transaction
3rd Feb 20207:00 amRNSLoan Facilities Agreement
10th Jan 202012:45 pmRNSGrant of Share Options
10th Jan 202010:20 amRNSResult of AGM
24th Dec 20197:00 amRNSPublication of Annual Report and Notice of AGM
6th Dec 20197:00 amRNSAppointment of Chief Executive Officer ("CEO")
5th Dec 20197:00 amRNSFinal results for the year ended 30 June 2019
22nd Oct 20197:00 amRNSBlocklisting Return
30th Sep 20197:00 amRNSUpdate on Strategic Review
24th Sep 20197:00 amRNSDirectorate Change
19th Sep 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSUpdate on Strategic Review
16th Jul 20198:00 amRNSPublication of Research
2nd Jul 20197:00 amRNSStrategic Review
5th Jun 20197:00 amRNSUpdate on off-take discussions
23rd Apr 20197:00 amRNSBlocklisting Return
28th Mar 20197:00 amRNSInterim results for the 6 months ended 31 Dec 2018
19th Feb 20197:00 amRNSPlacing to raise £1.1 million
14th Feb 20197:00 amRNSUpdate on bulk sampling programme
18th Jan 201911:30 amRNSResult of AGM
18th Jan 20197:00 amRNSCompany Update
21st Dec 201810:25 amRNSNotice of AGM
7th Dec 20187:00 amRNSFinal results for the year ended 30 June 2018
19th Nov 20187:00 amRNSPlacing to raise £400,000
7th Nov 20182:15 pmRNSNotification of major holdings
22nd Oct 20187:00 amRNSBlock listing Interim Review
26th Sep 20187:00 amRNSIronveld supplies potential off-take partner
12th Jul 20185:02 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSBlocklisting Return
28th Mar 20187:00 amRNSInterim results for the 6 months ended 31 Dec 2017
28th Feb 20187:00 amRNSCompany Update
31st Jan 20189:00 amRNSHolding(s) in Company
23rd Jan 20185:18 pmRNSResult of AGM
23rd Jan 20189:45 amRNSTR-1: Notification of major holdings
19th Dec 20177:00 amRNSAppointment of Non-Executive Director
7th Dec 20177:00 amRNSFinal results for the year ended 30 June 2017
27th Nov 20177:00 amRNSPlacing to raise £1.765 million
30th Oct 201712:10 pmRNSHolding(s) in Company
23rd Oct 20177:00 amRNSBlocklisting Return
12th Oct 20177:00 amRNSCompany Update
4th Oct 201710:45 amRNSHolding(s) in Company
25th Jul 20179:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.